Compartment Syndrome of All Extremities in the Setting of COVID-19-Induced Systemic Capillary Leak Syndrome With Superimposed Myositis

• Published in: Curēus (Palo Alto, CA) Vol. 15; no. 7; p. e41368
• Main Authors: Zeller, Robert B, Morehouse, Casey, Lindsey, Tom, Provisor, Aaron, Naylor, Michael J
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 04-07-2023; Cureus
• Subjects: Cardiac/Thoracic/Vascular Surgery; Compartment syndrome; COVID-19; Cysts; Dyspnea; Emergency medical care; Hemoglobin; Hospitals; Infectious Disease; Inflammatory diseases; Kinases; Musculoskeletal diseases; Orthopedics; Patients; Rhabdomyolysis; Ultrasonic imaging; emergency fasciotomy; covid 19; systemic capillary leak syndrome; viral myositis; microvascular complications; bilateral compartment syndrome
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.41368

Three years following the pandemic's emergence, COVID-19 has continued to affect much of the symptomatic population with widely varied respiratory complaints, fevers, numerous unexpected prodromal manifestations, and unknown long-term consequences. Scattered cases involving myopathies, rhabdomyolysis, and compartment syndrome have also been reported throughout the pandemic. Some similar cases have been attributed to systemic capillary leak syndrome (SCLS). Here, we report the development of compartment syndrome involving all extremities in a 57-year-old vaccinated female known to have COVID-19. In retrospect, we believe the clinical severity and the patient's sudden deterioration can also be attributed to the lesser-known SCLS. Treatment required fasciotomies of both forearms, arms, and legs. This is the most significantly involved case, leading to survival reported thus far. Lab abnormalities, misleading imaging, and symmetric involvement of all extremities posed a significant challenge to proper diagnosis and treatment. This case serves as a reminder for providers to remain cognizant of neurovascular emergencies during the workup of critically ill patients when the presentation is unrecognized and usual treatments are refractory. Its purpose is also to contribute to the global understanding of and response to COVID-19.